DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer

참고문헌 (56)

1. Nakaya, N., "noxin, a novel stress-induced gene involved in cell cycle and apoptosis", Mol. Cell. Biol, 27, pp.5430~5444 (2007)
2. Won, K. J., "Human Noxin is an anti-apoptotic protein in response to DNA damage of A549 non-small cell lung carcinoma", Int. J. Cancer, 134, pp.2595~2604 (2014)
3. Zhang, X., "Noxin promotes proliferation of breast cancer cells via P38-ATF2signaling pathway", Tumour Biol, 39, pp.1010428317705515~ (2017)
4. Liu, N., "DDIAS promotes invasion and proliferation of non-small cell lung cancer and predicts poor survival of lung cancer patients", Int. J. Clin. Exp. Pathol, 10, pp.11506~11515 (2017)
5. Zhang, Z. Z., "NOXIN as a cofactor of DNA polymerase-primase complex could promote hepatocellular carcinoma", Int. J. Cancer, 137, pp.765~775 (2015)
6. Im, J. Y., "DNA damage-induced apoptosis suppressor(DDIAS), a novel target of NFATc1, is associated with cisplatin resistance in lung cancer", Biochim. Biophys. Acta, 1863, pp.40~49 (2016)
7. Im, J. Y., "DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells", Oncogene, 37, pp.1251~1262 (2018)
8. Im, J. Y., "DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells", Oncogenesis, 9, pp.1~ (2020)
9. Dueva, R., "Replication protein A: a multifunctional protein with roles in DNA replication, repair and beyond", NAR Cancer, 2, pp.zcaa022~ (2020)
10. Wold, M. S., "Replication protein A : a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism", Annu. Rev. Biochem, 66, pp.61~92 (1997)
11. Iftode, C., "Replication protein A(RPA) : the eukaryotic SSB", Crit. Rev. Biochem. Mol. Biol, 34, pp.141~180 (1999)
12. Akimov, V., "UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites", Nat. Struct. Mol. Biol, 25, pp.631~640 (2018)
13. Im, J. Y., "DNA damage induced apoptosis suppressor(DDIAS)is upregulated via ERK5", MEF2B signaling and promotes beta-catenin-mediated invasion, 2016, pp.1859, 1449~1458
14. Mancini, M., "NFAT proteins : emerging roles in cancer progression", Nat. Rev. Cancer, 9, pp.810~820 (2009)
15. Muller, M. R., "NFAT, immunity and cancer : a transcription factor comes of age", Nat. Rev. Immunol, 10, pp.645~656 (2010)
16. Lakin, N. D., "Regulation of p53 in response to DNA damage", Oncogene, 18, pp.7644~7655 (1999)
17. Lopez-Camarillo, C., "Protein kinases and transcription factors activation in response to UV-radiation of skin : implications for carcinogenesis", Int. J. Mol. Sci, 13, pp.142~172 (2012)
18. Kato, Y., "BMK1", ERK5 regulates serum-induced early gene expression through transcription factor MEF2C, 1997, pp.16, 7054~7066
19. Kato, Y., "Bmk1", Erk5 is required for cell proliferation induced by epidermal growth factor, 1998, pp.395, 713~716
20. Im, J. Y., "Data on the transcriptional regulation of DNA damage induced apoptosis suppressor(DDIAS)by ERK5", MEF2B pathway in lung cancer cells, 2016, pp.9, 257~261
21. Won, K. J., "Stability of the cancer target DDIAS is regulated by the CHIP", HSP70 pathway in lung cancer cells, 2017, pp.8, e2554~
22. Paul, I., "The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity", Oncogene, 32, pp.1284~1295 (2013)
23. Ferreira, J. V., "STUB1", CHIP is required for HIF1A degradation by chaperonemediated autophagy, 2013, pp.9, 1349~1366
24. Wang, S., "CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer", Gut, 62, pp.496~508 (2013)
25. Brunette, G. J., "Evolution-based screening enables genome-wide prioritization and discovery of DNA repair genes", Proc. Natl Acad. Sci. U. S. A, 116, pp.19593~19599 (2019)
26. Scully, R., "DNA double-strand break repairpathway choice in somatic mammalian cells", Nat. Rev. Mol. Cell Biol, 20, pp.698~714 (2019)
27. Chapman, J. R., "Playing the end game: DNA doublestrand break repair pathway choice", Mol. Cell, 47, pp.497~510 (2012)
28. Chen, R., "Replication protein A: single-stranded DNA’s first responder: dynamic DNA-interactions allow replication protein A to direct singlestrand DNA intermediates into different pathways for synthesis or repair", Bioessays, 36, pp.1156~1161 (2014)
29. Bromberg, J. F., "Stat3 as an oncogene", Cell, 98, pp.295~303 (1999)
30. Yu, H., "The STATs of cancer-new molecular targets come of age", Nat. Rev. Cancer, 4, pp.97~105 (2004)
31. Yu, H., "STATs in cancer inflammation and immunity : a leading role for STAT3", Nat. Rev. Cancer, 9, pp.798~809 (2009)
32. Huynh, J., "Therapeutically exploiting STAT3activity in cancer-using tissue repair as a road map", Nat. Rev. Cancer, 19, pp.82~96 (2019)
33. Bhattacharya, S., "STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells", Biochem. J, 392, pp.335~344 (2005)
34. Xie, T. X., "Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis", Oncogene, 23, pp.3550~3560 (2004)
35. Gritsko, T., "Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells", Clin. Cancer Res, 12, pp.11~19 (2006)
36. Zhong, Z., "Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6", Science, 264, pp.95~98 (1994)
37. Hillmer, E. J., "STAT3 signaling in immunity", Cytokine Growth Factor Rev, 31, pp.1~15 (2016)
38. Shuai, K., "Regulation of JAK-STAT signalling in the immune system", Nat. Rev. Immunol, 3, pp.900~911 (2003)
39. Takeiwa, T., "PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2", Sci. Rep, 12, pp.9495~ (2022)
40. Mitobe, Y., "PSF promotes ER-positive breast cancer progression via posttranscriptional regulation of ESR1 and SCFD2", Cancer Res, 80, pp.2230~2242 (2020)
41. Yeh, H. W., "PSPC1 mediates TGF-beta1 autocrine signalling and Smad2", 3target switching to promote EMT, stemness and metastasis, 2018, pp.20, 479~491
42. Lang, Y. D., "PSPC1-interchanged interactions with PTK6 and beta-catenin synergize oncogenic subcellular translocations and tumor progression", Nat. Commun, 10, pp.5716~ (2019)
43. Zhang, L., "Mechanisms of resistance to TRAIL-induced apoptosis in cancer", Cancer Gene Ther, 12, pp.228~237 (2005)
44. Trivedi, R., "Trailing TRAIL resistance : novel targets for TRAIL sensitization in cancer cells", Front. Oncol, 5, pp.69~ (2015)
45. Roberts, T. C., "Advances in oligonucleotide drug delivery", Nat. Rev. Drug Discov, 19, pp.673~694 (2020)
46. Hu, B., "Therapeutic siRNA : state of the art", Signal Transduct. Target. Ther, 5, pp.101~ (2020)
47. Muralidharan, R., "HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer", Cancer Gene Ther, 22, pp.581~590 (2015)
48. Muralidharan, R., "Tumor-targeted nanoparticle delivery of HuR siRNA inhibits lung tumor growth in vitro and in vivo by disrupting the oncogenic activity of the RNA-binding protein HuR", Mol. Cancer Ther, 16, pp.1470~1486 (2017)
49. Im Joo-Young, "DGG-100629 inhibits lung cancer growth by suppressing the NFATc1", DDIAS, Experimental and Molecular Medicine, pp.2021, 53[DOI]
50. Hong, D., "AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer", Sci. Transl. Med, 7, pp.314~ (2015)
51. Fagard, R., "STAT3 inhibitors for cancer therapy: Have all roads been explored?", JAKSTAT, 2, pp.e22882~ (2013)
52. Dong, J., "Recent update on development of small-molecule STAT3 inhibitors for cancer therapy : from phosphorylation inhibition to protein degradation", J. Med. Chem, 64, pp.8884~8915 (2021)
53. Yoon, S. H., "Miconazole inhibits signal transducer and activator of transcription 3 signaling by preventing its interaction with DNA damage-induced apoptosis suppressor", Cancer Sci, 111, pp.2499~2507 (2020)
54. Ershov, N. I., "Consequences of early life stress on genomic landscape of H3K4me3 in prefrontal cortex of adult mice", BMC Genom, 19, pp.93~ (2018)
55. Chiarelli, N., "Molecular insights in the pathogenesis of classical Ehlers-Danlos syndrome from transcriptome-wide expression profiling of patients’ skin fibroblasts", PLoS One, 14, pp.e0211647~ (2019)
56. Charkoftaki, G., "Identification of dose-dependent DNA damage and repair responses from subchronic exposure to 1, 4-dioxane in mice using a systems analysis approach", Toxicol. Sci, 183, pp.338~351 (2021)

관련 논문AI추천